Benjamin F. Holt

Ben has played a leading role in some of the most significant antitrust litigation matters in recent years, successfully defeating the Federal Trade Commission in a groundbreaking lawsuit over Louisiana Children’s Medical Center’s $150 million acquisition of three New Orleans area hospitals that raised important issues of state action immunity, obtaining summary judgment for Takeda Pharmaceuticals in a case addressing the contours of Noerr-Pennington immunity in the pharmaceutical industry, and serving as lead counsel for Viatris in three long-running cases brought by dozens of US states and territories alleging industry-wide price fixing and market allocation. His practice encompasses all types of antitrust litigation and investigations, including class actions, DOJ and FTC investigations, and state attorney general litigation.

In his antitrust counseling practice, Ben leverages his litigation experience to advise clients on a wide variety of business issues that may raise competition concerns.  He also provides guidance on compliance with federal and state antitrust laws and has experience in a range of industries, including the life sciences, financial services, and automotive sectors.

Ben is a frequent speaker, presenting to clients and others on antitrust developments and topics such as trade association antitrust compliance and class action defense strategies. He has published numerous articles on antitrust and litigation topics and is the co-editor of Global Competition Review's "Private Litigation Know How" publication and the co-author of Antitrust Compliance, published by Bloomberg BNA as part of the Corporate Practice series.